(Q37662519)

21 August 2017

1 reference

title

Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes - an update (English)

1 reference

21 August 2017

0 references

0 references

Britta Fischer

1

1 reference

21 August 2017

Dana Elias

series ordinal

2

1 reference

21 August 2017

Reinhard G Bretzel

series ordinal

3

1 reference

21 August 2017

Thomas Linn

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Expert Opinion on Biological Therapy

21 August 2017

1 reference

21 August 2017

10

1 reference

21 August 2017

2

1 reference

21 August 2017

265-272

1 reference

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Five-year follow-up after clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Predicting type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Peptide therapy for Type I diabetes: the immunological homunculus and the rationale for vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

GAD treatment and insulin secretion in recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Improved efficacy of a tolerizing DNA vaccine for reversal of hyperglycemia through enhancement of gene expression and localization to intracellular sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Regulatory T cells and immune computation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903555176

10.1517/14712590903555176

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference